NCT07392411Recruiting
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
Source: ClinicalTrials.gov · Last updated 6 Feb 2026
Brief summary (registry, in English)
This research employs AI to analyze facial expressions and speech patterns, aiming to develop new digital tools for diagnosing and differentiating Parkinson's disease and similar disorders.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 720 (estimated)
- First submitted
- 30 Jan 2026
- Start date
- 25 Jul 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Beijing Tiantan Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT07392411
What you commit to
- Study type: Observational
- Planned participants: 720
- From 25 Jul 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of cerebrovascular disease, head trauma, hydrocephalus, brain tumors, or intracranial surgery.
- Presence of metal implants, cardiac pacemakers, or other metallic foreign bodies (applies to PD patients).
Other
- Severe dyskinesia in PD patients that would compromise cooperation with video/audio recording.
- Mini-Mental State Examination (MMSE) score ≤ 24 points.
Who the study is looking for
- Inclusion Criteria for Parkinson's Disease (PD) Group: (1) Diagnostic Criteria: Meet the diagnostic criteria for Parkinson's disease established by the Movement Disorder Society (MDS) in 2015. (2) Age Range: 18-75 years old. (3) Disease Severity: Early-stage PD: Hoehn-Yahr score ≤ 2.5 points. Mid-to-late-stage PD: Hoehn-Yahr score 2.5-5 points. (4) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (5) Informed Consent: Signed informed consent form.
- Inclusion Criteria for Parkinson's Plus Syndromes (MSA-P, PSP) Group: (1) Age Range: 18-75 years old. (2) Diagnostic Criteria: MSA patients must meet the diagnostic criteria established by the \[Chinese Expert Consensus on the Diagnosis of Multiple System Atrophy, 2017\]. PSP patients must meet the diagnostic criteria established by the \[Chinese Clinical Diagnostic Criteria for Progressive Supranuclear Palsy, 2016 Edition\]. (3) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (4) Informed Consent: Signed informed consent form.
Age in the registry: 15 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.